openPR Logo
Press release

EAES Congress 2011: Italian market launch of the new and innovative r2 DRIVE instruments

06-14-2011 06:41 AM CET | Health & Medicine

Press release from: Tuebingen Scientific Medical GmbH

EAES Congress 2011: Italian market launch of the new

Tübingen, June 10th, 2011 – Tuebingen Scientific Medical GmbH, producer of deflectable, laparoscopic instruments, presents the new radius r2 SERIES at the EAES Congress (European Association for Endoscopic Surgery) in Torino, Italy.

In cooperation with the local specialists from Euromedical S.r.l., Brescia, the new
r2 DRIVE instruments will be presented to the international audience on the EAES Congress. At the same time this event will host the local market launch of this innovative product line into the Italian market.

“We are happy that, after reaching CE mark and successfully launching the products to the German market, we are now able to present r2 DRIVE to the international audience on the EAES Congress.” states Prof. Marc O. Schurr, Managing Director of Tuebingen Scientific. “Feedback from the German market shows that there is interest and – more important – a big need for our flexible instruments. In a short timeframe we were able to place orders in general surgery as well as in gynecology and urology.”

The local representation in Italy is Euromedical S.r.l., an experienced and well established medical company with an excellent reputation. “We are very excited about the ability to add these highly innovative and unique products of Tuebingen Scientific to our product portfolio.” states Ilario Bonera, President of Euromedical. ”We are looking forward to the EAES Congress which will be our official launch event for the Italian market.”

The radius r2 SERIES includes two complementary lines: r2 DRIVE and r2 CURVE. The laparoscopic surgeon is thus equipped with instruments that optimally support him with the degrees of freedom normally offered by robotic systems in traditional laparoscopic interventions as well as in single port surgery.

r2 DRIVE has been CE certified and is thus available for clinical use. The second version r2 CURVE will be released in the next months.

r2 DRIVE – for laparascopic surgery
r2 DRIVE is a hand-held instrument that offers all degrees of freedom of a robotic system. A distinctive feature is the flexibility of the sequence of movements. Due to the 90°-deflectable and rotatable tip, in combination with the rotatable shaft, surgical maneuvers can be confidently and precisely carried out even in difficult angles and tight spaces.
The unique operating concept of the instrument enables surgical intervention in areas that would otherwise be inaccessible. The instrument is primarily controlled with the fingertips, thereby offering utmost precision and total comfort for the surgeon. Extensive movements are thus rendered superfluous, which obviates fatigue and discomfort on the part of the surgeon.
The shaft diameter is 5 mm, enabling body access through small incisions.
Bipolar HF technology provides secure, reproducible and clearly defined effects in preparation and hemostasis.
The instrument will be available in various configurations: atraumatic forceps, needle holder, dissector and scissors. In this way, different operative manipulations can be carried out in various medical disciplines.
The radius r2 SERIES is a disposable, one-piece instrument without time-consuming assembly or recycling.

Tuebingen Scientific:
Tuebingen Scientific Medical GmbH develops innovative surgical instruments with a clear focus on an optimal cost : benefit ratio. Our goal is to produce innovative technologies which create a significant value add for medical personnel and patients and which are – with respect to application and price structure – suitable for daily use in hospitals. Tuebingen Scientific was founded by experts who have extensive knowledge of technology development and minimally invasive surgical procedures. Today the company is run by a team of experts with extensive technical, clinical and marketing knowledge and skills. For more information please visit www.tuebingen-scientific.com.

Tuebingen Scientific Medical GmbH
Mrs. Heike Debaets
Dorfackerstr. 26
72074 Tübingen
Germany
Tel: + 49 7071 98979 145
Fax: + 49 7071 98979 240
E-Mail: pr@tuebingen-scientific.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release EAES Congress 2011: Italian market launch of the new and innovative r2 DRIVE instruments here

News-ID: 178966 • Views:

More Releases from Tuebingen Scientific Medical GmbH

The intelligent symbiosis of robotic, traditional and single port interventions in MIC
The intelligent symbiosis of robotic, traditional and single port interventions …
Tübingen, May 3, 2011 – Tuebingen Scientific Medical GmbH, producer of deflectable, laparoscopic instruments, presents the new radius r2 SERIES at the Congress of the German Society of Surgery. The various minimally invasive procedures offer advantages as well as disadvantages for surgeons and for patients. A new concept combines several benefits of the individual procedures and therefore offers a decisive value add. The degrees of freedom and
Tuebingen Scientific announces the CE certification of the new r2 DRIVE, deflectable, laparoscopic instruments
Tuebingen Scientific announces the CE certification of the new r2 DRIVE, deflect …
The r2 DRIVE has been CE certified and can thus be clinically used in the European Union. „We are happy to introduce the r2 DRIVE to daily clinical application. After excellent results in preclinical use, operators and patients can now benefit from this new, innovative instrument,“ says engineer Marcus Braun, Managing Director and CTO of Tuebingen Scientific Medical GmbH. „The special features of the instrument series are

More Releases for EAES

Laparoscopy Devices Market Offering Trends, Share, Size, Growth Until the End of …
Risk of Aerosolization of Coronavirus May Hamper Market Growth The laparoscopy devices market is projected to experience a slowdown during the COVID-19 outbreak, as minimally invasive surgical procedures carry the risk of aerosolization of blood-borne viruses. The SAGE (Scientific Advisory Group for Emergencies) and the EAES (European Association for Endoscopic Surgeons) have recommended patients to postpone their surgeries if not urgent due to the ongoing coronavirus outbreak. SAGE and EAES have laid
Bariatric Surgery Market Size, Share & Growth Analysis And Regional Forecast, 20 …
The Bariatric Surgery Market Research Reports 2021 – 2027 is an Analysis and In-depth study of the Bariatric Surgery Market Industry, with the target of global market trend. The report mainly focuses on the market size, market structure, market share, growth cost structure, and forecast for 2027. The Research Report is an analysis of quantitative of the Bariatric Surgery market and gives information for making strategies to developing the Bariatric
direct/ Simbionix Announces Immediate Availability of Its Newest Module for Trai …
Industry´s First Module That Uses Simulation for the Teaching and Practice of Laparoscopic Hernia Treatment Procedures CLEVELAND, OH and LOD, ISRAEL -- (MARKET WIRE) -- August 09, 2006 -- Simbionix announces the availability of a new add-on module for the teaching and practice of laparoscopic ventral hernia procedures. First of its kind in the industry, the LAP Hernia module is the latest addition to the suite of laparoscopic procedures developed for